BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 38774935)

  • 21. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.
    Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Fukushima Y; Hori M; Miura K; Takada Y; Nakata K; Sakata KI
    J Radiat Res; 2020 Mar; 61(2):265-274. PubMed ID: 32009177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.
    Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T
    Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer.
    Wang X; Li J; Wang P; Yuan K; Yin G; Wan B
    J Contemp Brachytherapy; 2016 Apr; 8(2):122-7. PubMed ID: 27257416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose-rate interstitial brachytherapy for gynecologic malignancies--dosimetric changes during treatment period.
    Onoe T; Nose T; Yamashita H; Yoshioka M; Toshiyasu T; Kozuka T; Oguchi M; Nakagawa K
    J Radiat Res; 2013 Jul; 54(4):663-70. PubMed ID: 23297319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage Re-irradiation With Single-modality Interstitial Brachytherapy for the Treatment of Recurrent Gynaecological Tumours in the Pelvis: A Multi-institutional Study.
    Raziee H; D'Souza D; Velker V; Barnes E; Taggar A; Mendez L; Leung E
    Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):43-51. PubMed ID: 31402286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective analysis of local recurrence pattern by computed tomography image-guided intracavitary and interstitial brachytherapy for locally advanced cervical cancer in a single Japanese institution.
    Umezawa R; Tokunaga H; Yamamoto T; Shigeta S; Takahashi N; Takeda K; Suzuki Y; Kishida K; Ito K; Kadoya N; Shimada M; Jingu K
    Brachytherapy; 2023; 22(4):477-486. PubMed ID: 37208225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy.
    Schnell E; Thompson S; Ahmad S; Herman TS; De La Fuente Herman T
    Med Dosim; 2020 Spring; 45(1):21-27. PubMed ID: 31101569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix - a retrospective study.
    Bandyopadhyay A; Ghosh AK; Chhatui B; Das D
    Rep Pract Oncol Radiother; 2021; 26(2):170-178. PubMed ID: 34211766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
    Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
    Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outpatient template-guided permanent interstitial brachytherapy using
    Feddock J; Aryal P; Steber C; Edwards J; Cheek D; Randall M
    Brachytherapy; 2017; 16(2):393-401. PubMed ID: 28139423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study.
    Otani Y; Ohno T; Ando K; Murata K; Kato S; Noda SE; Murofushi K; Ushijima H; Yoshida D; Okonogi N; Isohashi F; Wakatsuki M; Nakano T
    J Radiat Res; 2021 May; 62(3):502-510. PubMed ID: 33532828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
    Mendez LC; Weiss Y; D'Souza D; Ravi A; Barbera L; Leung E
    Radiother Oncol; 2017 May; 123(2):312-318. PubMed ID: 28351521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique.
    Yin G; Wang P; Lang J; Tian Y; Luo Y; Fan Z; Tam KY
    J Contemp Brachytherapy; 2016 Jun; 8(3):221-32. PubMed ID: 27504132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation.
    Murofushi KN; Tanaka R; Ohkawa A; Numajiri H; Minakami S; Okumura T; Sakurai H
    J Contemp Brachytherapy; 2022 Feb; 14(1):60-65. PubMed ID: 35233236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
    Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
    Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosimetric predictors of local control and complications in gynecologic transperineal implant patients: The medical college of wisconsin experience.
    Zeitlin R; Yu G; Wheatley M; Morrow N; Rownd J; Rein L; Banerjee A; Bedi M; Erickson B
    Brachytherapy; 2022; 21(1):94-109. PubMed ID: 34937684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Yang W; Wu X
    Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer.
    Murakami N; Kasamatsu T; Wakita A; Nakamura S; Okamoto H; Inaba K; Morota M; Ito Y; Sumi M; Itami J
    BMC Cancer; 2014 Jun; 14():447. PubMed ID: 24938757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.